James R Meyers - Net Worth and Insider Trading

James R Meyers Net Worth

The estimated net worth of James R Meyers is at least $198,874 dollars as of 2024-03-28. James R Meyers is the EVP Worldwide Commercial Ops of Gilead Sciences Inc and owns about 2,715 shares of Gilead Sciences Inc (GILD) stock worth over $198,874. Details can be seen in James R Meyers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James R Meyers has not made any transactions after 2018-01-16 and currently still holds the listed stock(s).

Transaction Summary of James R Meyers

To

James R Meyers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James R Meyers owns 4 companies in total, including CytomX Therapeutics Inc () , Arbutus Biopharma Corp () , and Sangamo Therapeutics Inc () among others .

Click here to see the complete history of James R Meyers’s form 4 insider trades.

Insider Ownership Summary of James R Meyers

Ticker Comapny Transaction Date Type of Owner
CytomX Therapeutics Inc 2018-12-20 director
Arbutus Biopharma Corp 2019-08-17 director
Sangamo Therapeutics Inc 2019-11-22 director
Gilead Sciences Inc 2018-01-16 EVP Worldwide Commercial Ops

James R Meyers Latest Holdings Summary

James R Meyers currently owns a total of 1 stock. James R Meyers owns 2,715 shares of Gilead Sciences Inc (GILD) as of January 16, 2018, with a value of $198,874.

Latest Holdings of James R Meyers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GILD Gilead Sciences Inc 2018-01-16 2,715 73.25 198,874

Holding Weightings of James R Meyers


James R Meyers Form 4 Trading Tracker

According to the SEC Form 4 filings, James R Meyers has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 100,000 shares on January 16, 2018, which brought James R Meyers around $8 Million.

Insider Trading History of James R Meyers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James R Meyers Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James R Meyers Ownership Network

Ownership Network List of James R Meyers

No Data

Ownership Network Relation of James R Meyers


James R Meyers Owned Company Details

What does CytomX Therapeutics Inc do?

Who are the key executives at CytomX Therapeutics Inc?

James R Meyers is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .

CytomX Therapeutics Inc () Insider Trades Summary

Over the past 18 months, James R Meyers made no insider transaction in CytomX Therapeutics Inc (). Other recent insider transactions involving CytomX Therapeutics Inc () include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc () in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytomX Therapeutics Inc Insider Transactions

No Available Data

James R Meyers Mailing Address

Above is the net worth, insider trading, and ownership report for James R Meyers. You might contact James R Meyers via mailing address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City Ca 94404.

Discussions on James R Meyers

No discussions yet.